Price to Book Value Chart

View Price to Book Value for NICXF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value Chart
Start Trial

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
September 04, 2026 0.0445
September 03, 2026 0.0445
September 02, 2026 0.0445
September 01, 2026 0.0445
August 31, 2026 0.0445
August 28, 2026 0.0445
August 27, 2026 0.0445
August 26, 2026 0.0445
August 25, 2026 0.0445
August 24, 2026 0.0445
August 21, 2026 0.0445
August 20, 2026 0.0445
August 19, 2026 0.0445
August 18, 2026 0.0445
August 17, 2026 0.0445
August 14, 2026 0.0445
August 13, 2026 0.0445
August 12, 2026 0.0445
August 11, 2026 0.0445
August 10, 2026 0.0445
August 07, 2026 0.0445
August 06, 2026 0.0445
August 05, 2026 0.0445
August 04, 2026 0.0445
August 03, 2026 0.0445
Date Value
July 31, 2026 0.0445
July 30, 2026 0.0445
July 29, 2026 0.0445
July 28, 2026 0.0445
July 27, 2026 0.0445
July 24, 2026 0.0445
July 23, 2026 0.0445
July 22, 2026 0.0445
July 21, 2026 0.0445
July 20, 2026 0.0445
July 17, 2026 0.0445
July 16, 2026 0.0445
July 15, 2026 0.0445
July 14, 2026 0.0445
July 13, 2026 0.0445
July 10, 2026 0.0445
July 09, 2026 0.0445
July 08, 2026 0.0445
July 07, 2026 0.0445
July 06, 2026 0.0445
July 02, 2026 0.0445
July 01, 2026 0.0445
June 30, 2026 0.0445
June 29, 2026 0.0445
June 26, 2026 0.0445

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
DBV Technologies SA 3.516
Cellectis SA 3.752
Genfit SA --
Innate Pharma SA --
Inventiva SA 2.132

Price to Book Value Related Metrics

PS Ratio 1.24
Price 0.30
Earnings Yield -16.03%
Market Cap 26.44M
Operating PE Ratio 7.075